April 14, 2026

Daraxonrasib Shows Significant OS Benefit in Metastatic Pancreatic Cancer – Targeted Oncology

April 14, 2026

New drug doubles one-year survival in pancreatic cancer trial – news.northwestern.edu

April 13, 2026

Daraxonrasib Shows “Unprecedented” Survival in Pretreated Pancreatic Cancer – CancerNetwork

April 10, 2026

OHSU research reveals how pancreatic cancer blocks immunotherapy – OHSU News

March 2, 2026

New minimally invasive endoscopic pancreatic cancer treatment shows promise for patients – WVU Medicine